US equities |
GOOGL $324.89 ▲+0.00% GOOG $321.89 ▲+0.00% MU $983.23 ▲+0.00% LITE $913.95 ▲+0.00% MSFT $531.01 ▲+0.00% SNDK $1,404.77 ▲+0.00% MRVL $251.65 ▲+0.00% SKHY $164.70 ▲+0.00%
FinancialContent

Latest News about Fragile X Syndrome

Recent news which mentions Fragile X Syndrome

Psychedelics And The Spectrum: Groundbreaking Study Details How One Firm Approaches Autism
Tickers NMLSF
Tags Contracts Top Stories Penny Stocks
From Benzinga
Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
Tickers KONEF NMLSF
Tags Psilocybin Microdosing KGK Sciences Markets
From Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
Tickers KONEF NMLSF
Tags Fragile X Syndrome Benzinga Markets
From Benzinga